» Articles » PMID: 20197451

RADAR Realistic Animal Model Series for Dose Assessment

Overview
Journal J Nucl Med
Specialty Nuclear Medicine
Date 2010 Mar 4
PMID 20197451
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Rodent species are widely used in the testing and approval of new radiopharmaceuticals, necessitating murine phantom models. As more therapy applications are being tested in animal models, calculating accurate dose estimates for the animals themselves becomes important to explain and control potential radiation toxicity or treatment efficacy. Historically, stylized and mathematically based models have been used for establishing doses to small animals. Recently, a series of anatomically realistic human phantoms was developed using body models based on nonuniform rational B-spline. Realistic digital mouse whole-body (MOBY) and rat whole-body (ROBY) phantoms were developed on the basis of the same NURBS technology and were used in this study to facilitate dose calculations in various species of rodents.

Methods: Voxel-based versions of scaled MOBY and ROBY models were used with the Vanderbilt multinode computing network (Advanced Computing Center for Research and Education), using geometry and tracking radiation transport codes to calculate specific absorbed fractions (SAFs) with internal photon and electron sources. Photon and electron SAFs were then calculated for relevant organs in all models.

Results: The SAF results were compared with values from similar studies found in reference literature. Also, the SAFs were used with standardized decay data to develop dose factors to be used in radiation dose calculations. Representative plots were made of photon electron SAFs, evaluating the traditional assumption that all electron energy is absorbed in the source organs.

Conclusion: The organ masses in the MOBY and ROBY models are in reasonable agreement with models presented by other investigators noting that considerable variation can occur between reported masses. Results consistent with those found by other investigators show that absorbed fractions for electrons for organ self-irradiation were significantly less than 1.0 at energies above 0.5 MeV, as expected for many of these small-sized organs, and measurable cross-irradiation was observed for many organ pairs for high-energy electrons (as would be emitted by nuclides such as (32)P, (90)Y, or (188)Re).

Citing Articles

Synthesis and Evaluation of Ga- and Lu-Labeled [diF-Pro]Bombesin(6-14) Analogs for Detection and Radioligand Therapy of Gastrin-Releasing Peptide Receptor-Expressing Cancer.

Wang L, Chen C, Chapple D, Wong A, Kurkowska S, Lau W Pharmaceuticals (Basel). 2025; 18(2).

PMID: 40006047 PMC: 11859184. DOI: 10.3390/ph18020234.


The heterobivalent (SSTR2/albumin) radioligand [Cu]Cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics.

Ullrich M, Wodtke R, Brandt F, Freudenberg R, Kotzerke J, Richter S Theranostics. 2024; 14(14):5371-5387.

PMID: 39310112 PMC: 11413788. DOI: 10.7150/thno.100091.


MIB Guides: Preclinical Radiopharmaceutical Dosimetry.

Carter L, Zanzonico P Mol Imaging Biol. 2023; 26(1):17-28.

PMID: 37964036 DOI: 10.1007/s11307-023-01868-9.


Lys-urea-Aad, Lys-urea-Cmc and Lys-urea-Cms as potential pharmacophores for the design of PSMA-targeted radioligands to reduce off-target uptake in kidneys and salivary glands.

Kuo H, Zhang Z, Zhang C, Merkens H, Tan R, Wong A Theranostics. 2023; 13(13):4559-4573.

PMID: 37649602 PMC: 10465233. DOI: 10.7150/thno.87663.


[Pb]Pb-eSOMA-01: A Promising Radioligand for Targeted Alpha Therapy of Neuroendocrine Tumors.

Chapeau D, Koustoulidou S, Handula M, Beekman S, de Ridder C, Stuurman D Pharmaceuticals (Basel). 2023; 16(7).

PMID: 37513897 PMC: 10384862. DOI: 10.3390/ph16070985.


References
1.
Muthuswamy M, Roberson P, Buchsbaum D . A mouse bone marrow dosimetry model. J Nucl Med. 1998; 39(7):1243-7. View

2.
Zankl M, Petoussi-Henss N, Fill U, Regulla D . The application of voxel phantoms to the internal dosimetry of radionuclides. Radiat Prot Dosimetry. 2003; 105(1-4):539-48. DOI: 10.1093/oxfordjournals.rpd.a006299. View

3.
Konijnenberg M, Bijster M, Krenning E, de Jong M . A stylized computational model of the rat for organ dosimetry in support of preclinical evaluations of peptide receptor radionuclide therapy with (90)Y, (111)In, or (177)Lu. J Nucl Med. 2004; 45(7):1260-9. View

4.
SNYDER W, Fisher Jr H, Ford M, Warner G . Estimates of absorbed fractions for monoenergetic photon sources uniformly distributed in various organs of a heterogeneous phantom. J Nucl Med. 1969; :Suppl 3:7-52. View

5.
Flynn A, Green A, Pedley R, Boxer G, Boden R, Begent R . A mouse model for calculating the absorbed beta-particle dose from (131)I- and (90)Y-labeled immunoconjugates, including a method for dealing with heterogeneity in kidney and tumor. Radiat Res. 2001; 156(1):28-35. DOI: 10.1667/0033-7587(2001)156[0028:ammfct]2.0.co;2. View